MustGrow Biologics sees massive growth in patent portfolio | News Direct

MustGrow Biologics sees massive growth in patent portfolio

News release by MustGrow Biologics Corp.

facebook icon linkedin icon twitter icon pinterest icon email icon Vancouver | March 13, 2023 12:19 PM Eastern Daylight Time

MustGrow Biologics CEO Corey Giasson joined Steve Darling from Proactive to share news the company has seen its portfolio of patents grow exponentially.

Giasson tells Proactive its IP portfolio has grown from 23 to 84 total patents issued and pending over the last three years. In fact, 62 have been issued which is an increase from 18 issued patents three years ago.

 

 

Contact Details

 

Proactive Canada

 

+1 604-688-8158

 

na-editorial@proactiveinvestors.com

Tags

proactiveinvestorsmustgrowbiologicscorptsxvmgrootcinvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews